226 filings
Page 2 of 12
8-K
4ppa yobk
9 Aug 22
NeoGenomics Reports Revenue of $125 Million in the Second Quarter
7:05am
8-K
qjykai
21 Jul 22
NeoGenomics Announces Chief Executive Officer Appointment
4:41pm
8-K/A
9b8c6ls1h x431
18 Jul 22
Departure of Directors or Certain Officers
4:31pm
8-K
mvb 8dj0uxy6wwlg8h6
3 Jun 22
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
oftnw
16 May 22
NeoGenomics Appoints Lynn Tetrault Interim CEO
10:13am
8-K
kqz4ct0x103hn41y8
11 May 22
NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary
5:02pm
8-K
r9xc09fmwajo8u 82
6 May 22
Departure of Directors or Certain Officers
4:34pm
8-K
fnwg8z zrd1sbbsnn5
27 Apr 22
NeoGenomics Reports Revenue of $117 Million in the First Quarter
7:19am
8-K
up90mkf8ahaafuju
25 Apr 22
Departure of Directors or Certain Officers
4:30pm
8-K
3pb8qzg4c
14 Apr 22
Other Events
4:23pm
8-K
m3b qld39qpk27wb7
28 Mar 22
NeoGenomics Announces CEO Departure and Initiates CEO Search
4:20pm
8-K
ynq9f vdm969son52
9 Mar 22
Departure of Directors or Certain Officers
8:57am
8-K
rp2fooe8ubp67bn
23 Feb 22
NeoGenomics Reports Full Year Revenue of $484 Million and Fourth Quarter Results
7:14am
8-K
b2o7g
19 Jan 22
Departure of Directors or Certain Officers
4:27pm
8-K
rmrh0nbvvuw
10 Nov 21
Departure of Directors or Certain Officers
5:06pm
8-K
h682gopo
4 Nov 21
NeoGenomics Reports Revenue of $121 Million
7:23am
8-K
p64mvxg
12 Oct 21
NeoGenomics Announces Board of Directors’ Transition
5:03pm
8-K/A
5t5jijx0g6oru
1 Sep 21
Consolidated financial statements
4:34pm
8-K
gs1u4ty0
10 Aug 21
Regulation FD Disclosure
5:09pm
8-K
174kwt27
6 Aug 21
NeoGenomics Reports 40% Revenue Growth to $122 Million
7:10am